Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Serena Nik-Zainal^{1

2}, Helen Davies³, Johan Staaf⁴, Manasa Ramakrishna³, Dominik Glodzik³, Xueqing Zou³, Inigo Martincorena³, Ludmil B Alexandrov^{3

5

6}, Sancha Martin³, David C Wedge³, Peter Van Loo^{3

7}, Young Seok Ju³, Marcel Smid⁸, Arie B Brinkman⁹, Sandro Morganella¹⁰, Miriam R Aure^{11

12}, Ole Christian Lingjærde^{12

13}, Anita Langerød^{11

12}, Markus Ringnér⁴, Sung-Min Ahn¹⁴, Sandrine Boyault¹⁵, Jane E Brock¹⁶, Annegien Broeks¹⁷, Adam Butler³, Christine Desmedt¹⁸, Luc Dirix¹⁹, Serge Dronov³, Aquila Fatima²⁰, John A Foekens⁸, Moritz Gerstung³, Gerrit K J Hooijer²¹, Se Jin Jang²², David R Jones³, Hyung-Yong Kim²³, Tari A King²⁴, Savitri Krishnamurthy²⁵, Hee Jin Lee²², Jeong-Yeon Lee²⁶, Yilong Li³, Stuart McLaren³, Andrew Menzies³, Ville Mustonen³, Sarah O'Meara³, Iris Pauporté²⁷, Xavier Pivot²⁸, Colin A Purdie²⁹, Keiran Raine³, Kamna Ramakrishnan³, F Germán Rodríguez-González⁸, Gilles Romieu³⁰, Anieta M Sieuwerts⁸, Peter T Simpson³¹, Rebecca Shepherd³, Lucy Stebbings³, Olafur A Stefansson³², Jon Teague³, Stefania Tommasi³³, Isabelle Treilleux³⁴, Gert G Van den Eynden^{19

35}, Peter Vermeulen^{19

35}, Anne Vincent-Salomon³⁶, Lucy Yates³, Carlos Caldas³⁷, Laura Van't Veer¹⁷, Andrew Tutt^{38

39}, Stian Knappskog^{40

41}, Benita Kiat Tee Tan^{42

43}, Jos Jonkers¹⁷, Åke Borg⁴, Naoto T Ueno²⁵, Christos Sotiriou¹⁸, Alain Viari^{44

45}, P Andrew Futreal^{3

46}, Peter J Campbell³, Paul N Span⁴⁷, Steven Van Laere¹⁹, Sunil R Lakhani^{31

48}, Jorunn E Eyfjord³², Alastair M Thompson^{29

49}, Ewan Birney¹⁰, Hendrik G Stunnenberg⁹, Marc J van de Vijver²¹, John W M Martens⁸, Anne-Lise Børresen-Dale^{11

12}, Andrea L Richardson^{16

20}, Gu Kong⁵⁰, Gilles Thomas⁵¹, Michael R Stratton⁵²

Affiliations

¹ Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. snz@sanger.ac.uk.
² East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 9NB, UK. snz@sanger.ac.uk.
³ Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
⁴ Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, SE-223 81, Sweden.
⁵ Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA.
⁶ Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico, 87545, USA.
⁷ Department of Human Genetics, University of Leuven, B-3000, Leuven, Belgium.
⁸ Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015CN, The Netherlands.
⁹ Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA, Nijmegen, The Netherlands.
¹⁰ European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK.
¹¹ Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, 0310, Norway.
¹² K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, 0310, Norway.
¹³ Department of Computer Science, University of Oslo, Oslo, Norway.
¹⁴ Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea.
¹⁵ Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373, Lyon Cedex 08, France.
¹⁶ Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, 02115, USA.
¹⁷ The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
¹⁸ Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000, Brussels, Belgium.
¹⁹ Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
²⁰ Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, USA.
²¹ Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
²² Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea.
²³ Department of Pathology, College of Medicine, Hanyang University, Seoul, 133-791, South Korea.
²⁴ Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.
²⁵ Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas, 77030, USA.
²⁶ Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea.
²⁷ Institut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513, Boulogne-Billancourt, France.
²⁸ University Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon, 25000, France.
²⁹ Pathology Department, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
³⁰ Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France.
³¹ The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland, 4029, Australia.
³² Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101, Reykjavik, Iceland.
³³ IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
³⁴ Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373, Lyon Cédex 08, France.
³⁵ Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium.
³⁶ Institut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248, Paris Cedex 05, France.
³⁷ Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.
³⁸ Breast Cancer Now Research Unit, King's College London, London, SE1 9RT, UK.
³⁹ Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, SW3 6JB, UK.
⁴⁰ Department of Clinical Science, University of Bergen, 5020, Bergen, Norway.
⁴¹ Department of Oncology, Haukeland University Hospital, 5021, Bergen, Norway.
⁴² National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore, Singapore.
⁴³ Singapore General Hospital, Outram Road, 169608, Singapore, Singapore.
⁴⁴ Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330, Montbonnot-Saint Martin, France. Alain.Viari@inria.fr.
⁴⁵ Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. Alain.Viari@inria.fr.
⁴⁶ Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas, 77230, USA.
⁴⁷ Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, 6525GA, The Netherlands.
⁴⁸ Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.
⁴⁹ Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas, 77030, USA.
⁵⁰ Department of Pathology, College of Medicine, Hanyang University, Seoul, 133-791, South Korea. gkong@hanyang.ac.kr.
⁵¹ Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France.
⁵² Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. mrs@sanger.ac.uk.

PMID: 30659290
DOI: 10.1038/s41586-019-0883-2

Published Erratum

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Serena Nik-Zainal et al. Nature. 2019 Feb.

. 2019 Feb;566(7742):E1.

doi: 10.1038/s41586-019-0883-2.

Authors

Affiliations

¹ Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. snz@sanger.ac.uk.
² East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 9NB, UK. snz@sanger.ac.uk.
³ Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
⁴ Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, SE-223 81, Sweden.
⁵ Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA.
⁶ Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico, 87545, USA.
⁷ Department of Human Genetics, University of Leuven, B-3000, Leuven, Belgium.
⁸ Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015CN, The Netherlands.
⁹ Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA, Nijmegen, The Netherlands.
¹⁰ European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK.
¹¹ Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, 0310, Norway.
¹² K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, 0310, Norway.
¹³ Department of Computer Science, University of Oslo, Oslo, Norway.
¹⁴ Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea.
¹⁵ Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373, Lyon Cedex 08, France.
¹⁶ Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, 02115, USA.
¹⁷ The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
¹⁸ Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000, Brussels, Belgium.
¹⁹ Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
²⁰ Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, USA.
²¹ Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
²² Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea.
²³ Department of Pathology, College of Medicine, Hanyang University, Seoul, 133-791, South Korea.
²⁴ Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.
²⁵ Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas, 77030, USA.
²⁶ Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea.
²⁷ Institut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513, Boulogne-Billancourt, France.
²⁸ University Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon, 25000, France.
²⁹ Pathology Department, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
³⁰ Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France.
³¹ The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland, 4029, Australia.
³² Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101, Reykjavik, Iceland.
³³ IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
³⁴ Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373, Lyon Cédex 08, France.
³⁵ Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium.
³⁶ Institut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248, Paris Cedex 05, France.
³⁷ Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.
³⁸ Breast Cancer Now Research Unit, King's College London, London, SE1 9RT, UK.
³⁹ Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, SW3 6JB, UK.
⁴⁰ Department of Clinical Science, University of Bergen, 5020, Bergen, Norway.
⁴¹ Department of Oncology, Haukeland University Hospital, 5021, Bergen, Norway.
⁴² National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore, Singapore.
⁴³ Singapore General Hospital, Outram Road, 169608, Singapore, Singapore.
⁴⁴ Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330, Montbonnot-Saint Martin, France. Alain.Viari@inria.fr.
⁴⁵ Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. Alain.Viari@inria.fr.
⁴⁶ Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas, 77230, USA.
⁴⁷ Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, 6525GA, The Netherlands.
⁴⁸ Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.
⁴⁹ Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas, 77030, USA.
⁵⁰ Department of Pathology, College of Medicine, Hanyang University, Seoul, 133-791, South Korea. gkong@hanyang.ac.kr.
⁵¹ Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France.
⁵² Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. mrs@sanger.ac.uk.

PMID: 30659290
DOI: 10.1038/s41586-019-0883-2

Abstract

In the Methods section of this Article, 'greater than' should have been 'less than' in the sentence 'Putative regions of clustered rearrangements were identified as having an average inter-rearrangement distance that was at least 10 times greater than the whole-genome average for the individual sample. '. The Article has not been corrected.

PubMed Disclaimer

Erratum for

Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, Aure MR, Lingjærde OC, Langerød A, Ringnér M, Ahn SM, Boyault S, Brock JE, Broeks A, Butler A, Desmedt C, Dirix L, Dronov S, Fatima A, Foekens JA, Gerstung M, Hooijer GK, Jang SJ, Jones DR, Kim HY, King TA, Krishnamurthy S, Lee HJ, Lee JY, Li Y, McLaren S, Menzies A, Mustonen V, O'Meara S, Pauporté I, Pivot X, Purdie CA, Raine K, Ramakrishnan K, Rodríguez-González FG, Romieu G, Sieuwerts AM, Simpson PT, Shepherd R, Stebbings L, Stefansson OA, Teague J, Tommasi S, Treilleux I, Van den Eynden GG, Vermeulen P, Vincent-Salomon A, Yates L, Caldas C, van't Veer L, Tutt A, Knappskog S, Tan BK, Jonkers J, Borg Å, Ueno NT, Sotiriou C, Viari A, Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, Martens JW, Børresen-Dale AL, Richardson AL, Kong G, Thomas G, Stratton MR. Nik-Zainal S, et al. Nature. 2016 Jun 2;534(7605):47-54. doi: 10.1038/nature17676. Epub 2016 May 2. Nature. 2016. PMID: 27135926 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Affiliations

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources